Potential role of soluble CD40 receptor in chronic inflammatory diseases
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential role of soluble CD40 receptor in chronic inflammatory diseases
Authors
Keywords
-
Journal
BIOCHEMICAL PHARMACOLOGY
Volume 217, Issue -, Pages 115858
Publisher
Elsevier BV
Online
2023-10-18
DOI
10.1016/j.bcp.2023.115858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ectodomain Shedding by ADAM17 Increases the Release of Soluble CD40 from Human Endothelial Cells under Pro-Inflammatory Conditions
- (2023) Anton Klersy et al. Cells
- Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk
- (2022) Simone Leonetti et al. ATHEROSCLEROSIS
- CD40–CD40L in Neurological Disease
- (2022) Heather D. Ots et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Attenuation of Excess TNF-α Release in Crohn’s Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking
- (2022) Taylor J. Louis et al. Frontiers in Immunology
- Role of CD40 ligand-mediated endothelial cell-monocyte interaction at atherosclerosis predilection sites
- (2022) S. Lont et al. BIOCHEMICAL PHARMACOLOGY
- A functional variant of CD40 modulates clearance of hepatitis B virus in hepatocytes via regulation of the ANXA2/CD40/BST2 axis
- (2022) Jiaxuan Chen et al. HUMAN MOLECULAR GENETICS
- The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
- (2021) Sebastian Meltzer et al. BRITISH JOURNAL OF CANCER
- Inflammatory activation of surface molecule shedding by upregulation of the pseudoprotease iRhom2 in colon epithelial cells
- (2021) Anja Adelina Giese et al. Scientific Reports
- Soluble CD40 Levels in Plasma Are Associated with Cardiovascular Disease and in Carotid Plaques with a Vulnerable Phenotype
- (2021) Annelie Shami et al. Journal of Stroke
- Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease
- (2021) Luisa Agnello et al. Diagnostics
- Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
- (2020) Henrik Zetterberg et al. MOLECULAR PSYCHIATRY
- The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
- (2020) Laura A. Bosmans et al. Journal of Cardiovascular Translational Research
- Identification of Four Potential Biomarkers Associated With Coronary Artery Disease in Non-diabetic Patients by Gene Co-expression Network Analysis
- (2020) Min Jiao et al. Frontiers in Genetics
- Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint
- (2020) TingTing Tang et al. PHARMACOLOGY & THERAPEUTICS
- Letter to the editor: “The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients”
- (2019) Ilce V. Román-Fernández et al. CLINICAL RHEUMATOLOGY
- Assessment of CD40 and CD40L expression in rheumatoid arthritis patients, association with clinical features and DAS28
- (2019) Ilce Valeria Román-Fernández et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Functional association of a CD40 gene single-nucleotide polymorphism with the pathogenesis of coronary heart disease
- (2019) Cheryl S Sultan et al. CARDIOVASCULAR RESEARCH
- Novel functions of inactive rhomboid proteins in immunity and disease
- (2019) Ramasatyaveni Geesala et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis
- (2019) S -C Bae et al. LUPUS
- rs1883832: a CD40 single-nucleotide polymorphism for predicting coronary heart disease in humans
- (2019) Esther Lutgens CARDIOVASCULAR RESEARCH
- Association of soluble CD40 levels with ‐1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus
- (2019) Raziel Tapia‐Llanos et al. Molecular Genetics & Genomic Medicine
- iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE
- (2018) Ioanna Oikonomidi et al. eLife
- Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study
- (2018) Angela C. Shore et al. DIABETES CARE
- ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
- (2018) Sai Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
- (2018) Jodi L. Karnell et al. ADVANCED DRUG DELIVERY REVIEWS
- The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients
- (2018) Taghreed G. Mousa et al. CLINICAL RHEUMATOLOGY
- ComPaSS-GWAS: A method to reduce type I error in genome-wide association studies when replication data are not available
- (2018) Jeremy A. Sabourin et al. GENETIC EPIDEMIOLOGY
- Association of CSF CD40 levels and synaptic degeneration across the Alzheimer’s disease spectrum
- (2018) Xinwu Ye et al. NEUROSCIENCE LETTERS
- The immunology of hypertension
- (2017) Allison E. Norlander et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression
- (2017) Yanxia Guo et al. JOURNAL OF IMMUNOLOGY
- Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis
- (2017) Jiaxuan Qin et al. Oncotarget
- Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE
- (2017) Miguel Cavadas et al. Cell Reports
- Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling
- (2017) Adam Graham Grieve et al. eLife
- Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease
- (2017) Jeffrey X. Xie et al. Scientific Reports
- Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in MiceHighlights
- (2016) Alexandros Nicolaou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
- (2016) Rawan Tarawneh et al. JAMA Neurology
- A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis
- (2015) Stefano Rizza et al. ATHEROSCLEROSIS
- The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus
- (2015) Jian-Ming Chen et al. BMC GENETICS
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- SNP location helps predict disease aetiology
- (2015) Liesbet Lieben NATURE REVIEWS GENETICS
- The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function
- (2015) Judith Field et al. PLoS One
- Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus
- (2015) Cheng-Jiang Wu et al. RHEUMATOLOGY INTERNATIONAL
- Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis B
- (2015) HONG-HUI SHEN et al. Experimental and Therapeutic Medicine
- Loss of TIMP3 exacerbates atherosclerosis in ApoE null mice
- (2014) Robert Stöhr et al. ATHEROSCLEROSIS
- Identification of Cleavage Sites Leading to the Shed Form of the Anti-Aging Protein Klotho
- (2014) Ci-Di Chen et al. BIOCHEMISTRY
- LC–MS Based Cleavage Site Profiling of the Proteases ADAM10 and ADAM17 Using Proteome-Derived Peptide Libraries
- (2014) Joanna Tucher et al. JOURNAL OF PROTEOME RESEARCH
- Polo-like Kinase 2, a Novel ADAM17 Signaling Component, Regulates Tumor Necrosis Factor α Ectodomain Shedding
- (2013) Jeanette Schwarz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- iRhom2 is required for the secretion of mouse TNF
- (2012) O. M. Siggs et al. BLOOD
- Impact of the CD40-CD40L Dyad in Alzheimers Disease
- (2012) Brian Giunta et al. CNS & Neurological Disorders-Drug Targets
- iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS
- (2012) D. R. McIlwain et al. SCIENCE
- Tyrosine nitration limits stretch-induced CD40 expression and disconnects CD40 signaling in human endothelial cells
- (2011) A. H. Wagner et al. BLOOD
- SNPedia: a wiki supporting personal genome annotation, interpretation and analysis
- (2011) Michael Cariaso et al. NUCLEIC ACIDS RESEARCH
- Association of CD40 Gene Polymorphisms with Sporadic Breast Cancer in Chinese Han Women of Northeast China
- (2011) Chen Shuang et al. PLoS One
- A common polymorphism in CD40 Kozak sequence (-1C/T) is associated with acute coronary syndrome
- (2010) Caixia Tian et al. BIOMEDICINE & PHARMACOTHERAPY
- Association analysis of CD40 gene polymorphism with acute coronary syndrome
- (2010) Jinchuan Yan et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Association between serum levels of soluble CD40/CD40 ligand and organ damage in hypertensive patients
- (2010) Ming Yuan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- CD40/SCD40 imbalance in hemodialysis patients
- (2010) Pasquale Esposito et al. CLINICAL BIOCHEMISTRY
- Direct Activation of TACE-Mediated Ectodomain Shedding by p38 MAP Kinase Regulates EGF Receptor-Dependent Cell Proliferation
- (2010) Pinglong Xu et al. MOLECULAR CELL
- Annexin A2 as a differential diagnostic marker of hepatocellular tumors
- (2010) Thomas Longerich et al. PATHOLOGY RESEARCH AND PRACTICE
- CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility
- (2010) Fiona Blanco-Kelly et al. PLoS One
- Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study
- (2009) G. Orozco et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of a single-nucleotide polymorphism inCD40with the rate of joint destruction in rheumatoid arthritis
- (2009) Michael P. M. van der Linden et al. ARTHRITIS AND RHEUMATISM
- Genetic risk factors for rheumatoid arthritis differ in caucasian and Korean populations
- (2009) Hye-Soon Lee et al. ARTHRITIS AND RHEUMATISM
- CD40 and autoimmunity: The dark side of a great activator
- (2009) Anna L. Peters et al. SEMINARS IN IMMUNOLOGY
- A functional TNFRSF5 gene variant is associated with risk of lymphoma
- (2008) C. F. Skibola et al. BLOOD
- Diagnostic utility of APOE, soluble CD40, CD40L, and Aβ1–40 levels in plasma in Alzheimer’s disease
- (2008) Ghania Ait-ghezala et al. CYTOKINE
- Characterization of natural human antagonistic soluble CD40 isoforms produced through alternative splicing
- (2008) Dani Eshel et al. MOLECULAR IMMUNOLOGY
- Common variants at CD40 and other loci confer risk of rheumatoid arthritis
- (2008) Soumya Raychaudhuri et al. NATURE GENETICS
- Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease
- (2008) Peder Buchhave et al. NEUROSCIENCE LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started